## JULIE NANGIA

| | Title| Associate Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Medicine  
Address| 7200 CAMBRIDGE  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=OKo%2b5mzGQIn2S8Ho5G4%3d&rnd=0d2979b4-c5ba-4bc9-a3c5-4b8f66eb92c4)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=266130)  
  
![](https://profiles.viictr.org/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=266130&cachekey=787c3461-d223-4ae2-864a-a9f3d9972cb1)  
  

Other Positions| Title| Associate Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Duncan Cancer Center  
Division| Cancer Center  
  
  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Freedman RA, Heiling HM, Li T, Trapani D, [Tayob N](https://profiles.viictr.org/profile/18883240), Smith KL, Davis R, Pereslete AM, DeMeo MK, Cotter C, Chen WY, Parsons HA, Santa-Maria CA, Van Poznak C, Moy B, Brufsky AM, Melisko ME, O'Sullivan CC, Ashai N, Rauf Y, **Nangia JR** , Burns RT, Savoie J, Wolff AC, Winer EP, [Rimawi MF](https://profiles.viictr.org/profile/269416), Krop IE, Lin NU. Neratinib and Ado-Trastuzumab-Emtansine for Pre-treated and Untreated HER2-positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium Trial 022. Ann Oncol. 2024 Jul 06. PMID: [38977064](//www.ncbi.nlm.nih.gov/pubmed/38977064).

Citations:  Fields:

Neo Neoplasms

  2. Buchanan A, Sarfo A, Rangel ML, **Nangia J** , [Badr H](https://profiles.viictr.org/profile/16943318). A mixed-methods study to inform development of a caregiver-specific problem list for cancer distress screening. Psychooncology. 2023 Oct; 32(10):1578-1585. PMID: [37698499](//www.ncbi.nlm.nih.gov/pubmed/37698499).

Citations:  Fields:

Neo NeoplasmsPsy Psychology

  3. [Veeraraghavan J](https://profiles.viictr.org/profile/3010617), [Gutierrez C](https://profiles.viictr.org/profile/265496), De Angelis C, Davis R, Wang T, Pascual T, Selenica P, Sanchez K, Nitta H, Kapadia M, Pavlick AC, Galvan P, Rexer B, Forero-Torres A, Nanda R, Storniolo AM, Krop IE, Goetz MP, **Nangia JR** , Wolff AC, Weigelt B, Reis-Filho JS, [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), Prat A, Osborne CK, [Schiff R](https://profiles.viictr.org/profile/269128), [Rimawi MF](https://profiles.viictr.org/profile/269416). A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer. Clin Cancer Res. 2023 08 15; 29(16):3101-3109. PMID: [37195235](//www.ncbi.nlm.nih.gov/pubmed/37195235); PMCID: [PMC10923553](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10923553).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37195235/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  4. Strand SH, Rivero-Guti?rrez B, Houlahan KE, Seoane JA, King LM, Risom T, Simpson LA, Vennam S, Khan A, Cisneros L, Hardman T, Harmon B, Couch F, Gallagher K, Kilgore M, We S, DeMichele A, King T, McAuliffe PF, **Nangia J** , Lee J, Tseng J, Storniolo AM, Thompson AM, Gupta GP, Burns R, Veis DJ, DeSchryver K, Zhu C, Matusiak M, Wang J, Zhu SX, Tappenden J, Ding DY, Zhang D, Luo J, Jiang S, Varma S, Anderson L, Straub C, Srivastava S, Curtis C, Tibshirani R, Angelo RM, Hall A, Owzar K, Polyak K, Maley C, Marks JR, Colditz GA, Hwang ES, West RB. Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts. Cancer Cell. 2023 Jul 10; 41(7):1381. PMID: [37433282](//www.ncbi.nlm.nih.gov/pubmed/37433282); PMCID: [PMC10416265](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10416265).

Citations:  Fields:

Neo Neoplasms

  5. Strand SH, Rivero-Guti?rrez B, Houlahan KE, Seoane JA, King LM, Risom T, Simpson LA, Vennam S, Khan A, Cisneros L, Hardman T, Harmon B, Couch F, Gallagher K, Kilgore M, Wei S, DeMichele A, King T, McAuliffe PF, **Nangia J** , Lee J, Tseng J, Storniolo AM, Thompson AM, Gupta GP, Burns R, Veis DJ, DeSchryver K, Zhu C, Matusiak M, Wang J, Zhu SX, Tappenden J, Ding DY, Zhang D, Luo J, Jiang S, Varma S, Anderson L, Straub C, Srivastava S, Curtis C, Tibshirani R, Angelo RM, Hall A, Owzar K, Polyak K, Maley C, Marks JR, Colditz GA, Hwang ES, West RB. Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts. Cancer Cell. 2022 12 12; 40(12):1521-1536.e7. PMID: [36400020](//www.ncbi.nlm.nih.gov/pubmed/36400020); PMCID: [PMC9772081](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9772081).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/36400020/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  6. [Anurag M](https://profiles.viictr.org/profile/15619466), Jaehnig EJ, Krug K, [Lei JT](https://profiles.viictr.org/profile/6998694), Bergstrom EJ, Kim BJ, Vashist TD, Huynh AMT, Dou Y, Gou X, Huang C, Shi Z, Wen B, Korchina V, [Gibbs RA](https://profiles.viictr.org/profile/269695), [Muzny DM](https://profiles.viictr.org/profile/268028), Doddapaneni H, Dobrolecki LE, Rodriguez H, Robles AI, Hiltke T, Lewis MT, **Nangia JR** , Nemati Shafaee M, Li S, Hagemann IS, Hoog J, Lim B, Osborne CK, Mani DR, Gillette MA, Zhang B, [Echeverria GV](https://profiles.viictr.org/profile/29680397), [Miles G](https://profiles.viictr.org/profile/18892308), [Rimawi MF](https://profiles.viictr.org/profile/269416), Carr SA, Ademuyiwa FO, Satpathy S, Ellis MJ. Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. Cancer Discov. 2022 11 02; 12(11):2586-2605. PMID: [36001024](//www.ncbi.nlm.nih.gov/pubmed/36001024); PMCID: [PMC9627136](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9627136).

Citations:

  7. [Hoyos V](https://profiles.viictr.org/profile/23479202), [Vasileiou S](https://profiles.viictr.org/profile/22016531), Kuvalekar M, Watanabe A, Tzannou I, Velazquez Y, French-Kim M, Leung W, [Lulla S](https://profiles.viictr.org/profile/34811365), Robertson C, Foreman C, Wang T, Bulsara S, [Lapteva N](https://profiles.viictr.org/profile/269143), [Grilley B](https://profiles.viictr.org/profile/266987), Ellis M, Osborne CK, Coscio A, **Nangia J** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), Vera JF, [Lulla P](https://profiles.viictr.org/profile/3010220), [Rimawi M](https://profiles.viictr.org/profile/269416), [Leen AM](https://profiles.viictr.org/profile/268626). Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer. Ther Adv Med Oncol. 2022; 14:17588359221107113. PMID: [35860837](//www.ncbi.nlm.nih.gov/pubmed/35860837); PMCID: [PMC9290161](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9290161).

Citations:

  8. Chevli N, Wang K, Haque W, [Schwartz MR](https://profiles.viictr.org/profile/267509), **Nangia J** , Sasaki J, Farach AM, Hatch SS, Butler EB, Teh BS. Prognostic Impact of Radiation Therapy in Pure Mucinous Breast Carcinoma. Clin Breast Cancer. 2022 10; 22(7):e807-e817. PMID: [35915020](//www.ncbi.nlm.nih.gov/pubmed/35915020).

Citations:

  9. Sanchez KG, **Nangia JR** , [Schiff R](https://profiles.viictr.org/profile/269128), [Rimawi MF](https://profiles.viictr.org/profile/269416). Elacestrant and the Promise of Oral SERDs. J Clin Oncol. 2022 10 01; 40(28):3227-3229. PMID: [35737918](//www.ncbi.nlm.nih.gov/pubmed/35737918).

Citations:  Fields:

Neo Neoplasms

  10. Ma CX, Luo J, Freedman RA, Pluard TJ, **Nangia JR** , Lu J, Valdez-Albini F, Cobleigh M, Jones JM, Lin NU, Winer EP, Marcom PK, Thomas S, Anderson J, Haas B, Bucheit L, Bryce R, Lalani AS, Carey LA, Goetz MP, Gao F, Kimmick G, Pegram MD, Ellis MJ, Bose R. The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer. Clin Cancer Res. 2022 04 01; 28(7):1258-1267. PMID: [35046057](//www.ncbi.nlm.nih.gov/pubmed/35046057).

Citations:  Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  11. **Nangia JR** , [Rimawi MF](https://profiles.viictr.org/profile/269416). Breast Cancer Prevention: Where Are We? JCO Oncol Pract. 2021 12; 17(12):720-722. PMID: [34618555](//www.ncbi.nlm.nih.gov/pubmed/34618555).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  12. Higashiyama N, **Nangia J** , Shafaee MN, Chen N, [Michael BL](https://profiles.viictr.org/profile/268573), [Rimawi M](https://profiles.viictr.org/profile/269416), [Hoyos V](https://profiles.viictr.org/profile/23479202). Dose-reduced trastuzumab deruxtecan can be safely used in liver failure and active leptomeningeal metastases. Curr Probl Cancer Case Rep. 2020 Dec 15; 2. PMID: [34505091](//www.ncbi.nlm.nih.gov/pubmed/34505091); PMCID: [PMC8425325](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8425325).

Citations:

  13. Lehmann BD, Abramson VG, Sanders ME, Mayer EL, Haddad TC, Nanda R, Van Poznak C, Storniolo AM, **Nangia JR** , Gonzalez-Ericsson PI, Sanchez V, Johnson KN, Abramson RG, Chen SC, Shyr Y, Arteaga CL, Wolff AC, Pietenpol JA, Translational Breast Cancer Research Consortium. TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer. Clin Cancer Res. 2020 05 01; 26(9):2111-2123. PMID: [31822498](//www.ncbi.nlm.nih.gov/pubmed/31822498); PMCID: [PMC7196503](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7196503).

Citations:
[33](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31822498/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  14. [Rimawi MF](https://profiles.viictr.org/profile/269416), Niravath P, Wang T, Rexer BN, Forero A, Wolff AC, Nanda R, Storniolo AM, Krop I, Goetz MP, **Nangia JR** , Jiralerspong S, Pavlick A, [Veeraraghavan J](https://profiles.viictr.org/profile/3010617), De Angelis C, [Gutierrez C](https://profiles.viictr.org/profile/265496), [Schiff R](https://profiles.viictr.org/profile/269128), [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), Osborne CK, Translational Breast Cancer Research Consortium. TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer. Clin Cancer Res. 2020 02 15; 26(4):821-827. PMID: [31662331](//www.ncbi.nlm.nih.gov/pubmed/31662331).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31662331/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  15. Haque W, Verma V, Suzanne Klimberg V, **Nangia J** , Schwartz M, Brian Butler E, Teh BS. Clinical presentation, national practice patterns, and outcomes of breast adenomyoepithelioma. Breast J. 2020 04; 26(4):653-660. PMID: [31578797](//www.ncbi.nlm.nih.gov/pubmed/31578797).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31578797/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  16. Freedman RA, Gelman RS, Agar NYR, Santagata S, Randall EC, Connolly RM, Dunn IF, Van Poznak CH, Anders CK, Melisko ME, Silvestri K, Cotter CM, Componeschi KP, Marte JM, Moy B, Blackwell KL, Puhalla SL, [Ibrahim N](https://profiles.viictr.org/profile/12582894), Moynihan TJ, **Nangia J** , Tung N, Burns R, [Rimawi MF](https://profiles.viictr.org/profile/269416), Krop IE, Wolff AC, Winer EP, Lin NU, Translational Breast Cancer Research Consortium (TBCRC), Gimenez-Cassina Lopez B. Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022. Clin Breast Cancer. 2020 04; 20(2):145-151.e2. PMID: [31558424](//www.ncbi.nlm.nih.gov/pubmed/31558424); PMCID: [PMC7035200](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7035200).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31558424/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  17. Niravath P, [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), Wang T, Jiralerspong S, **Nangia J** , Pavlick A, Ademuyiwa F, Frith A, Ma C, Park H, Rigden C, Suresh R, Ellis M, Kent Osborne C, [Rimawi MF](https://profiles.viictr.org/profile/269416). Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia. Breast Cancer Res Treat. 2019 Sep; 177(2):427-435. PMID: [31218477](//www.ncbi.nlm.nih.gov/pubmed/31218477).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31218477/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  18. Freedman RA, Gelman RS, Anders CK, Melisko ME, Parsons HA, Cropp AM, Silvestri K, Cotter CM, Componeschi KP, Marte JM, Connolly RM, Moy B, Van Poznak CH, Blackwell KL, Puhalla SL, Jankowitz RC, Smith KL, [Ibrahim N](https://profiles.viictr.org/profile/12582894), Moynihan TJ, O'Sullivan CC, **Nangia J** , Niravath P, Tung N, Pohlmann PR, Burns R, [Rimawi MF](https://profiles.viictr.org/profile/269416), Krop IE, Wolff AC, Winer EP, Lin NU, Translational Breast Cancer Research Consortium. TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases. J Clin Oncol. 2019 05 01; 37(13):1081-1089. PMID: [30860945](//www.ncbi.nlm.nih.gov/pubmed/30860945); PMCID: [PMC6494354](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6494354).

Citations:
[107](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30860945/citedby/)
Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  19. Johnston AN, Bu W, Hein S, Garcia S, Camacho L, Xue L, Qin L, [Nagi C](https://profiles.viictr.org/profile/6998780), [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), [Kapali J](https://profiles.viictr.org/profile/23496078), **Nangia J** , Li Y, Podsypanina K. Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions. Breast Cancer Res. 2018 05 19; 20(1):42. PMID: [29778097](//www.ncbi.nlm.nih.gov/pubmed/29778097); PMCID: [PMC5960176](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5960176).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29778097/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  20. Freites-Martinez A, Shapiro J, Goldfarb S, **Nangia J** , Jimenez JJ, Paus R, Lacouture ME. Hair disorders in patients with cancer. J Am Acad Dermatol. 2019 May; 80(5):1179-1196. PMID: [29660422](//www.ncbi.nlm.nih.gov/pubmed/29660422); PMCID: [PMC6186204](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6186204).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29660422/citedby/) Fields:

Der Dermatology

Translation:Humans

  21. **Nangia J**. Quality of Life Matters: It Is Time to Integrate Scalp Cooling in Routine Clinical Practice. J Oncol Pract. 2018 03; 14(3):157-158. PMID: [29529388](//www.ncbi.nlm.nih.gov/pubmed/29529388).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29529388/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  22. Gucalp A, Zhou XK, Cook ED, Garber JE, Crew KD, **Nangia JR** , Bhardwaj P, Giri DD, Elemento O, Verma A, Wang H, Lee JJ, Vornik LA, Mays C, Weber D, Sepeda V, O'Kane H, Krasne M, Williams S, Morris PG, Heckman-Stoddard BM, Dunn BK, Hudis CA, Brown PH, Dannenberg AJ. A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease. Cancer Prev Res (Phila). 2018 04; 11(4):203-214. PMID: [29453232](//www.ncbi.nlm.nih.gov/pubmed/29453232); PMCID: [PMC6290902](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6290902).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29453232/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  23. **Nangia J** , Wang T, Osborne C, Niravath P, Otte K, Papish S, Holmes F, Abraham J, Lacouture M, Courtright J, Paxman R, Rude M, [Hilsenbeck S](https://profiles.viictr.org/profile/268374), Osborne CK, [Rimawi M](https://profiles.viictr.org/profile/269416). Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial. JAMA. 2017 02 14; 317(6):596-605. PMID: [28196254](//www.ncbi.nlm.nih.gov/pubmed/28196254).

Citations:
[45](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28196254/citedby/) Fields:

Med Medicine (General)

Translation:HumansPHPublic Health

  24. Forero-Torres A, Varley KE, Abramson VG, Li Y, Vaklavas C, Lin NU, Liu MC, Rugo HS, Nanda R, Storniolo AM, Traina TA, Patil S, Van Poznak CH, **Nangia JR** , Irvin WJ, Krontiras H, De Los Santos JF, Haluska P, Grizzle W, Myers RM, Wolff AC, Translational Breast Cancer Research Consortium (TBCRC). TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer. Clin Cancer Res. 2015 Jun 15; 21(12):2722-9. PMID: [25779953](//www.ncbi.nlm.nih.gov/pubmed/25779953); PMCID: [PMC6186432](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6186432).

Citations:
[33](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25779953/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  25. Paoletti C, Li Y, Kidwell KM, Aung K, Thomas DG, Brown ME, Abramson VG, Irvin WJ, Lin NU, Liu MC, Nanda R, **Nangia JR** , Storniolo AM, Traina TA, Vaklavas C, Van Poznak CH, Wolff AC, Forero-Torres A, Hayes DF, Translational Breast Cancer Research Consortium (TBCRC), Mu?iz MC. Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019. Clin Cancer Res. 2015 Jun 15; 21(12):2771-9. PMID: [25779948](//www.ncbi.nlm.nih.gov/pubmed/25779948); PMCID: [PMC5521206](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5521206).

Citations:
[39](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25779948/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  26. Bilen MA, [Laucirica R](https://profiles.viictr.org/profile/266515), [Rimawi MF](https://profiles.viictr.org/profile/269416), **Nangia JR** , [Cyprus GS](https://profiles.viictr.org/profile/267561). Jejunal intussusception due to malignant phyllodes tumor of the breast. Clin Breast Cancer. 2012 Jun; 12(3):219-21. PMID: [22381472](//www.ncbi.nlm.nih.gov/pubmed/22381472).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22381472/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  27. **Nangia JR** , Ma JD, [Nguyen CM](https://profiles.viictr.org/profile/34089586), Mendes MA, [Trivedi MV](https://profiles.viictr.org/profile/270103). Denosumab for treatment of breast cancer bone metastases and beyond. Expert Opin Biol Ther. 2012 Apr; 12(4):491-501. PMID: [22348344](//www.ncbi.nlm.nih.gov/pubmed/22348344).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22348344/citedby/) Fields:

Bio BiologyThe Therapeutics

Translation:HumansAnimals

  28. **Nangia JR** , Lakhani AA, Loew JM, Gregory SA. Multiple myeloma with multiple extramedullary plasmacytomas. Clin Adv Hematol Oncol. 2011 Aug; 9(8):630-2. PMID: [22236993](//www.ncbi.nlm.nih.gov/pubmed/22236993).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22236993/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:Humans

  29. Khandelwal A, Shah NB, Eichenseer P, Welker M, Miller I, **Nangia J** , Farhat M, Gimelfarb A, Kassar M, Batus M, Gezer S, Shammo J, Gregory S, Fung H, Venugopal P. Idiopathic hemophagocytic syndrome with a fulminant clinical course. Clin Adv Hematol Oncol. 2008 Aug; 6(8):587-90. PMID: [18820601](//www.ncbi.nlm.nih.gov/pubmed/18820601).

Citations:  Fields:

Hem HematologyNeo Neoplasms

Translation:Humans

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 29 publications over 12 distinct years, with a maximum of
6 publications in 2019 and
2022](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|6&cht=bvs&chd=t:0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,0,0,17,33,0,0,33,0,17,67,100,17,17,100,50,17&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2008| 1  
2011| 1  
2012| 2  
2015| 2  
2017| 1  
2018| 4  
2019| 6  
2020| 1  
2021| 1  
2022| 6  
2023| 3  
2024| 1  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

NANGIA's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (131)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Alopecia](https://profiles.viictr.org/profile/247322)
  * [Breast Neoplasms](https://profiles.viictr.org/profile/256408)
  * [Physical Therapy Modalities](https://profiles.viictr.org/profile/241926)
  * [Hypothermia, Induced](https://profiles.viictr.org/profile/245512)
  * [Scalp](https://profiles.viictr.org/profile/241315)

[Explore](https://profiles.viictr.org/profile/266130/198)

_

Co-Authors (31)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [RIMAWI, MOTHAFFAR](https://profiles.viictr.org/profile/269416)
  * [TRIVEDI, MEGHANA](https://profiles.viictr.org/profile/270103)
  * [HOYOS, VALENTINA](https://profiles.viictr.org/profile/23479202)
  * [HILSENBECK, SUSAN](https://profiles.viictr.org/profile/268374)
  * [VEERARAGHAVAN, JAMUNARANI](https://profiles.viictr.org/profile/3010617)

[Explore](https://profiles.viictr.org/profile/266130/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [HUNT, KELLY K](https://profiles.viictr.org/profile/12582914)
  * [KANTARJIAN, HAGOP M](https://profiles.viictr.org/profile/12582901)
  * [KUERER, HENRY MARK](https://profiles.viictr.org/profile/12582567)
  * [MITTENDORF, ELIZABETH ANN](https://profiles.viictr.org/profile/12583070)
  * [MERIC-BERNSTAM, FUNDA](https://profiles.viictr.org/profile/12583329)

[Explore](https://profiles.viictr.org/profile/266130/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [HILSENBECK, SUSAN](https://profiles.viictr.org/profile/268374)
  * [MOAKE, JOEL](https://profiles.viictr.org/profile/268005)
  * [SONNET, CORINNE](https://profiles.viictr.org/profile/15317746)
  * [SULLIVAN, CATHY](https://profiles.viictr.org/profile/269017)
  * [YEN, AIHUA](https://profiles.viictr.org/profile/270002)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=A81BSfTwU3GNm4liSODkW6vB3EBYO6gz+a5TY1bFhuz1tc7ngL4Orww3064KoquG+9VriFtrDjogfSknlN6Jz7ictMT0qk3g10zM0TMIEPsEyvmx6bLpcnNFGJ4exv4/fFAesBf4NHrkI4nVpsBeSKg1prKuDu5Ad3xZR2IG1VXzQt2Kl5Hs5a708T2/vlG+0DSye5g9KBjG4Q1kuBhnZAsDzRQkDR38klnZT2UlnG774nyA2dru0SIu9XaJe2Vd5sGS5MfW+ZRpNT79jDpQICGGFNfg5WTlXIPkbYJjpf3YGfCjPCJ3A81UJRyGY9MF14VFc7hjK08KUw/CXldSQkQX94mkjqn1GRbJZcV6q8YMdcbUB3UeVgUHmLQA7INKLsictgHvVcL1tc7ngL4Or2BgPoCYhvcEdI9fj5a9U4/8OigV51+oglRnSu//SLHvjH1HWb7OWmYrCEOhNlmBq7Z/PsLHWsJSZIAfV8346VMVWsQSiN3oIGGN9jLXSZC010kNGYH6yvTtuL5pI2IiiZgevCUih0f3vmYbjqDWiC08TnyRrJKGE/Ija0iyg/oaKwhDoTZZgau2fz7Cx1rCUmSAH1fN+OlTFVrEEojd6CBhjfYy10mQtNdJDRmB+sr0qj61OBf+xqDD+6Clu8wvckIBgwTrFvbm7X3tdBvSWESSFAIovZGCSzP0EoNHt5PiUF26eANDXMkWXAx5IRPustF+EEOAWlaZMfmQk2RtrZ+2TvwExPPqANFJ7Ah6OupyjcQbuuaMR4JpF2jOOFZEaWue6vkhtoRwwfdN4TTmOan9ztqBxhOvMb+us3lPmnf2tt1S1Z0IDTE7qPP/7M2jzFN6foNWCqqLRb/LXAdoFsRpMPt345sB8SI9K3ixiSN+kccJVanciBCNm4liSODkW2tuMX0EQMJeJ1NvmZC7MMfIH0G3DzFa7Ww3kCPpSspax47lNl+obrMAl6LnDsmqO6LI4XK0QanMi19EAkvoFc7JmZNEJTRG2uqY8pTR84tJVXfmR7Dk5CJCe/cQ6H6rtg==)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [FUQUA, SUZANNE](https://profiles.viictr.org/profile/269832)
  * [MILLER-CHISM, COURTNEY](https://profiles.viictr.org/profile/3494080)
  * [RAMOS, CARLOS](https://profiles.viictr.org/profile/267038)
  * [SADA, YVONNE](https://profiles.viictr.org/profile/267158)
  * [YELLAPRAGADA, SARVARI](https://profiles.viictr.org/profile/267994)

_

